← FDA DRUG APPROVALS

FDA NDA · NDA021092

HELICOSOL

Sponsor: METABOLIC SOLUTIONS

APPLICATION
NDA021092
TYPE
NDA
ORIGINAL APPROVAL
1999-12-17
LATEST ACTION
2000-10-20
ROUTE
ORAL
DOSAGE FORM
FOR SOLUTION
MARKETING STATUS
Discontinued

Products

HELICOSOLDiscontinued
UREA C-13 125MG/VIAL · FOR SOLUTION · ORAL

Approval history

2000-10-20Manufacturing (CMC) · Supplement 1 · standardAP
1999-12-17Type 5 - New Formulation or New Manufacturer · Original · standardReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →